🔎 Trials Near Me

Akèy › Kolit Ulseratif › Kalifòni › Lancaster

Etid klinik pou Kolit Ulseratif nan Lancaster, CA

8 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Lancaster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Om Research, LLC, Lancaster
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 012, Lancaster
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Gastro Care Institute /ID# 281071, Lancaster
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07697456

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Ap rekriteFaz 2
  • Gastro Care Institute, Lancaster
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Om Research LLC, Lancaster
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • Om Research LLC, Lancaster
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Om Research, LLC - Lancaster - Site Number: 8400148, Lancaster
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Ap rekriteFaz 2
  • Investigational Site Number: 8400006, Lancaster
Laj 18 a 75 · Tout sèks · Mizajou Apr 23, 2026 · NCT06975722

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Lancaster

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.